Sphera Funds Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-323,373
| Closed | -$1.28M | – | 128 |
|
|
2018
Q4 | $1.28M | Hold |
323,373
| – | – | 0.14% | 83 |
|
|
2018
Q3 | $6.39M | Buy |
323,373
+126,475
| +64% | +$2.5M | 0.73% | 32 |
|
|
2018
Q2 | $6.25M | Buy |
196,898
+148,119
| +304% | +$4.7M | 0.86% | 28 |
|
|
2018
Q1 | $1.81M | Buy |
48,779
+8,779
| +22% | +$325K | 0.27% | 75 |
|
|
2017
Q4 | $3.16M | Buy |
+40,000
| New | +$3.16M | 0.37% | 63 |
|